BACKGROUND: KPC carbapenemase-producing Klebsiella pneumoniae isolates have been increasingly detected in Europe. We report the first KPC-producing isolates characterized in Madrid, Spain. METHODS: Twelve K. pneumoniae isolates recovered from clinical and surveillance cultures from eight patients (September 2009 to February 2010) that were resistant to carbapenems and resulted in a positive modified Hodge test, were screened for carbapenemase genes (PCR, sequencing and hybridization). Clonal relatedness was established by PFGE and multilocus sequence typing. Plasmid characterization included incompatibility group assay and XhoI/HindIII restriction pattern comparison. The genetic environment was characterized by PCR based on the Tn4401 sequence. RESULTS: All 12 isolates were resistant to all beta-lactams, including imipenem and meropenem (MIC >or= 8 mg/L). Eleven of them, fully susceptible to aminoglycosides and fluoroquinolones, showed related PFGE patterns and belonged to sequence type (ST) 384 and harboured the bla(KPC-3), bla(OKP-5), bla(OXA-9) and bla(TEM-1) genes, whereas one isolate resistant to quinolones belonged to ST388, and also harboured the bla(CTX-M-10) gene. The bla(KPC-3), bla(OXA-9) and bla(TEM-1) genes were located on an approximately 85 kb non-transferable plasmid that was a derivative of pKPN3/pKPN4 previously described in K. pneumoniae. The bla(KPC-3) gene was located on the Tn4401 'isoform a' variant, which is usually linked to bla(KPC-2), but rarely to bla(KPC-3). CONCLUSIONS: The emergence of Tn4401-bla(KPC-3) within a pKPN3/4-like plasmid and its novel association with ST384 and ST388 K. pneumoniae clones in Spain is reported. Although bla(KPC-3) has been scarcely reported in Europe, the location of this Tn4401a in a widespread K. pneumoniae plasmid supports the possibility of broader future dissemination.
BACKGROUND: KPC carbapenemase-producing Klebsiella pneumoniae isolates have been increasingly detected in Europe. We report the first KPC-producing isolates characterized in Madrid, Spain. METHODS: Twelve K. pneumoniae isolates recovered from clinical and surveillance cultures from eight patients (September 2009 to February 2010) that were resistant to carbapenems and resulted in a positive modified Hodge test, were screened for carbapenemase genes (PCR, sequencing and hybridization). Clonal relatedness was established by PFGE and multilocus sequence typing. Plasmid characterization included incompatibility group assay and XhoI/HindIII restriction pattern comparison. The genetic environment was characterized by PCR based on the Tn4401 sequence. RESULTS: All 12 isolates were resistant to all beta-lactams, including imipenem and meropenem (MIC >or= 8 mg/L). Eleven of them, fully susceptible to aminoglycosides and fluoroquinolones, showed related PFGE patterns and belonged to sequence type (ST) 384 and harboured the bla(KPC-3), bla(OKP-5), bla(OXA-9) and bla(TEM-1) genes, whereas one isolate resistant to quinolones belonged to ST388, and also harboured the bla(CTX-M-10) gene. The bla(KPC-3), bla(OXA-9) and bla(TEM-1) genes were located on an approximately 85 kb non-transferable plasmid that was a derivative of pKPN3/pKPN4 previously described in K. pneumoniae. The bla(KPC-3) gene was located on the Tn4401 'isoform a' variant, which is usually linked to bla(KPC-2), but rarely to bla(KPC-3). CONCLUSIONS: The emergence of Tn4401-bla(KPC-3) within a pKPN3/4-like plasmid and its novel association with ST384 and ST388 K. pneumoniae clones in Spain is reported. Although bla(KPC-3) has been scarcely reported in Europe, the location of this Tn4401a in a widespread K. pneumoniae plasmid supports the possibility of broader future dissemination.
Authors: Andrea Endimiani; Kristine M Hujer; Andrea M Hujer; Mark E Pulse; William J Weiss; Robert A Bonomo Journal: Antimicrob Agents Chemother Date: 2010-11-01 Impact factor: 5.191
Authors: Irene Rodríguez; Ângela Novais; Felipe Lira; Aránzazu Valverde; Tânia Curião; José Luis Martínez; Fernando Baquero; Rafael Cantón; Teresa M Coque Journal: Antimicrob Agents Chemother Date: 2015-02-17 Impact factor: 5.191
Authors: María Isabel Morosini; María García-Castillo; Marta Tato; Desirèe Gijón; Aránzazu Valverde; Patricia Ruiz-Garbajosa; Rafael Cantón Journal: J Clin Microbiol Date: 2014-02-26 Impact factor: 5.948
Authors: Leonardo Neves Andrade; Tânia Curiao; Joseane Cristina Ferreira; Juliana Mucedola Longo; Eduardo Carneiro Clímaco; Roberto Martinez; Fernando Bellissimo-Rodrigues; Aníbal Basile-Filho; Marco Antônio Evaristo; Pedro F Del Peloso; Vanessa Bley Ribeiro; Afonso Luis Barth; Milena Cristina Paula; Fernando Baquero; Rafael Cantón; Ana Lúcia da Costa Darini; Teresa M Coque Journal: Antimicrob Agents Chemother Date: 2011-05-16 Impact factor: 5.191
Authors: Renata Galetti; Leonardo Neves Andrade; Michael Chandler; Alessandro de Mello Varani; Ana Lúcia Costa Darini Journal: Antimicrob Agents Chemother Date: 2016-04-22 Impact factor: 5.191
Authors: Christopher Lucasti; Liviu Vasile; Dorel Sandesc; Donatas Venskutonis; Patrick McLeroth; Mallika Lala; Matthew L Rizk; Michelle L Brown; Maria C Losada; Alison Pedley; Nicholas A Kartsonis; Amanda Paschke Journal: Antimicrob Agents Chemother Date: 2016-09-23 Impact factor: 5.191